This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Corcept Therapeutics Incorporated, Carrick Therapeutics Limited. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 138 
1 out of 2 Years Active: 2023-2025
Title: Damien Francis Philippe Crepin: Innovator in Therapeutic Compounds
Introduction
Damien Francis Philippe Crepin is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of therapeutic compounds, holding a total of 3 patents. His work focuses on innovative solutions for various medical disorders, showcasing his expertise and dedication to advancing healthcare.
Latest Patents
Crepin's latest patents include groundbreaking inventions such as the 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino methyl]piperidin-3-ol compounds and their therapeutic use. This invention pertains to compounds that inhibit cyclin-dependent protein kinases (CDKs), particularly CDK12 and CDK13. These compounds not only selectively inhibit these CDKs but also act as selective Cyclin K degraders, enhancing their cellular potency and selectivity. The therapeutic applications of these compounds extend to treating various disorders, including cancer, viral infections, neurodegenerative disorders, and autoimmune diseases.
Another notable patent involves pyrimidine cyclohexenyl glucocorticoid receptor modulators. This invention provides a class of pyrimidinedione cyclohexenyl compounds and outlines methods for using these compounds as glucocorticoid receptor modulators, further emphasizing Crepin's innovative approach to therapeutic development.
Career Highlights
Throughout his career, Crepin has worked with prominent companies in the pharmaceutical sector, including Corcept Therapeutics Incorporated and Carrick Therapeutics Limited. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in therapeutic research.
Collaborations
Crepin has collaborated with notable colleagues such as Hazel Joan Hunt and Joseph Hill-Cousins. These partnerships have played a crucial role in the development of his innovative compounds and therapeutic strategies.
Conclusion
Damien Francis Philippe Crepin is a distinguished inventor whose work in therapeutic compounds has the potential to impact various medical fields significantly. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile